Dr. Cindy Ivanhoe, MD

NPI: 1740217397
Total Payments
$158,583
2024 Payments
$8,846
Companies
26
Transactions
392
Medicare Patients
586
Medicare Billing
$50,811

Payment Breakdown by Category

Consulting$61,390 (38.7%)
Other$58,225 (36.7%)
Food & Beverage$19,947 (12.6%)
Travel$18,818 (11.9%)
Gifts$120.00 (0.1%)
Education$83.76 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $61,390 20 38.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $58,225 21 36.7%
Food and Beverage $19,947 292 12.6%
Travel and Lodging $18,818 50 11.9%
Gift $120.00 2 0.1%
Education $83.76 7 0.1%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $76,830 114 $0 (2022)
Ipsen Biopharmaceuticals, Inc $26,459 61 $0 (2024)
ABBVIE INC. $15,674 49 $0 (2024)
Shionogi Inc $10,398 13 $0 (2020)
Medtronic USA, Inc. $7,872 45 $0 (2020)
Saol Therapeutics Inc. $4,640 12 $0 (2021)
Ipsen Innovation $4,546 7 $0 (2017)
Merz Pharmaceuticals, LLC $4,072 27 $0 (2024)
Flowonix Medical Incorporated $2,154 2 $0 (2022)
Medtronic, Inc. $1,925 20 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $8,846 37 ABBVIE INC. ($5,126)
2023 $3,399 36 Ipsen Biopharmaceuticals, Inc ($815.94)
2022 $20,743 58 ABBVIE INC. ($9,802)
2021 $19,345 30 Allergan, Inc. ($13,028)
2020 $18,051 32 Shionogi Inc ($10,398)
2019 $28,381 55 Allergan Inc. ($11,411)
2018 $23,120 86 Allergan Inc. ($13,683)
2017 $36,700 58 Allergan Inc. ($26,268)

All Payment Transactions

392 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/18/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $525.00 General
12/16/2024 ABBVIE INC. BOTOX (Biological) Consulting Fee Cash or cash equivalent $2,200.00 General
Category: FACIAL AESTHETICS
12/16/2024 ABBVIE INC. BOTOX (Biological) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: FACIAL AESTHETICS
12/12/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $23.05 General
Category: Neurology
11/09/2024 Medtronic, Inc. SYNCHROMEDII (Device) Food and Beverage In-kind items and services $70.96 General
Category: Drug Infusion Systems
11/06/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $66.74 General
Category: BOTOX THERAPEUTIC
11/06/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $56.25 General
Category: BOTOX THERAPEUTIC
10/25/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $145.12 General
Category: Neurology
10/24/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $26.71 General
Category: BOTOX THERAPEUTIC
10/15/2024 Nalu Medical, Inc. Nalu Neurostimulation System (Device) Food and Beverage In-kind items and services $117.02 General
Category: Pain Management
10/10/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $86.76 General
Category: Neurology
08/26/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $102.29 General
Category: BOTOX THERAPEUTIC
08/26/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $59.79 General
Category: Neurology
08/20/2024 Medtronic, Inc. SYNCHROMEDII (Device) Food and Beverage In-kind items and services $97.60 General
Category: Drug Infusion Systems
07/17/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $60.88 General
Category: Musculoskeletal
06/18/2024 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $3.36 General
Category: NEUROLOGY
06/01/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $24.31 General
Category: Neurology
05/21/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $149.94 General
Category: Neurology
05/15/2024 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $6.36 General
Category: NEUROLOGY
05/14/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $109.76 General
Category: Musculoskeletal
05/10/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $116.41 General
Category: Neuromodulation
05/01/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $29.31 General
Category: Musculoskeletal
04/09/2024 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $124.97 General
Category: NEUROLOGY
04/08/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $6.71 General
Category: BOTOX THERAPEUTIC
04/02/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $83.71 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 139 208 $54,171 $12,860
2022 6 133 226 $48,145 $11,862
2021 6 153 247 $46,551 $12,111
2020 5 161 259 $52,320 $13,978
Total Patients
586
Total Services
940
Medicare Billing
$50,811
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 26 34 $15,504 $3,196 20.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 22 28 $8,876 $2,187 24.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 14 31 $6,200 $2,013 32.5%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Office 2023 14 24 $9,720 $1,963 20.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 20 31 $3,193 $1,268 39.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 15 22 $4,906 $1,041 21.2%
64643 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Office 2023 11 14 $3,444 $819.11 23.8%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Office 2023 17 24 $2,328 $373.50 16.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 39 70 $14,000 $3,960 28.3%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Office 2022 16 33 $13,365 $2,690 20.1%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 39 64 $6,592 $1,915 29.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 14 15 $6,840 $1,789 26.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 11 14 $4,438 $1,043 23.5%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Office 2022 14 30 $2,910 $464.59 16.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 47 85 $17,000 $4,777 28.1%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 49 84 $8,652 $2,605 30.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 18 23 $7,291 $1,763 24.2%
64644 Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles Office 2021 12 19 $7,695 $1,647 21.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 15 21 $4,683 $1,081 23.1%
95873 Electrical stimulation for guidance with injection of chemical for destruction of muscles Office 2021 12 15 $1,230 $237.84 19.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 44 86 $17,200 $5,223 30.4%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 64 111 $11,433 $3,674 32.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 24 27 $12,312 $2,325 18.9%
64644 Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles Office 2020 13 19 $7,695 $1,694 22.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 16 16 $3,680 $1,062 28.9%

About Dr. Cindy Ivanhoe, MD

Dr. Cindy Ivanhoe, MD is a Physical Medicine & Rehabilitation healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740217397.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cindy Ivanhoe, MD has received a total of $158,583 in payments from pharmaceutical and medical device companies, with $8,846 received in 2024. These payments were reported across 392 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($61,390).

As a Medicare-enrolled provider, Ivanhoe has provided services to 586 Medicare beneficiaries, totaling 940 services with total Medicare billing of $50,811. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Location Houston, TX
  • Active Since 06/27/2006
  • Last Updated 02/08/2011
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1740217397

Products in Payments

  • BOTOX (Biological) $70,441
  • DYSPORT (Drug) $15,717
  • BOTOX NEURO REHAB (Drug) $9,544
  • BOTOX (Drug) $9,300
  • Dysport (Drug) $8,499
  • Dysport 300 U-1 (Drug) $8,054
  • Lioresal (baclofen) (Drug) $4,491
  • SYNCHROMED (Device) $4,293
  • Xeomin (Biological) $4,262
  • LIORESAL (Device) $2,617
  • Prometra II (Device) $2,154
  • SYNCHROMEDII (Device) $1,165
  • ADAPTIVESTIM (Device) $937.39
  • XEOMIN (Biological) $492.35
  • ASCENDA (Device) $422.05
  • BOTOX THERAPEUTIC (Biological) $397.72
  • NUEDEXTA (Drug) $347.74
  • GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) $279.49
  • HA MINUTEMAN G3-R (Device) $204.17
  • INTELLIS ADAPTIVESTIM (Device) $185.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Houston